ConductScience.org, home

Paper2248508

Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.

Ueda N and 2 others. Arch Dis Child, 1990. Cited by 52 papers, by iCite.

Cite this record

ConductScience Library. Eight and 12 week courses of cyclophosphamide in nephrotic syndrome. Papers, record 2248508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2248508

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.
PubMed
Journal
Arch Dis Child
PubMed
Year
1990
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
2.64
iCite
Revised in PubMed
2019-05-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ueda NN
2Kuno KK
3Ito SS

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CyclophosphamideMajor topic
Nephrosis, LipoidMajor topic
Child
Dose-Response Relationship, Drug
Drug Therapy, Combination
Female
Humans
Male
Prednisolone
Prospective Studies
Recurrence
Time Factors

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in2053810Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.https://conductscience.org/library/papers/2053810

Source PubMed

Download CSV of comments and corrections

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1621614Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy.J Pediatr1978https://conductscience.org/library/papers/621614PubMed
26229699Modulation of cellular immune function by cyclophosphamide in children with minimal-change nephropathy.N Engl J Med1984https://conductscience.org/library/papers/6229699PubMed
33335948Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome.J Pediatr1988https://conductscience.org/library/papers/3335948PubMed
44698338Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome.J Pediatr1973https://conductscience.org/library/papers/4698338PubMed
54339533Long-term follow-up of children with steroid-responsive nephrotic syndrome.J Pediatr1972https://conductscience.org/library/papers/4339533PubMed
6934751Cyclophosphamide in the treatment of idiopathic nephrotic syndrome.Pediatrics1976https://conductscience.org/library/papers/934751PubMed
74574639Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood.Arch Dis Child1973https://conductscience.org/library/papers/4574639PubMed
84855503Long-term follow-up of cyclophosphamide therapy in frequent relapsing minimal lesion nephrotic syndrome.J Pediatr1974https://conductscience.org/library/papers/4855503PubMed
94425844Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide.Br Med J1974https://conductscience.org/library/papers/4425844PubMed
1046019Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood.Lancet1975https://conductscience.org/library/papers/46019PubMed
111249681Gonadal function, testicular histology, and meiosis following cyclophosphamide therapy in patients with nephrotic syndrome.J Pediatr1976https://conductscience.org/library/papers/1249681PubMed

Download CSV of references

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
42867774Follow-up Outcomes of 100 Children with Frequently Relapsing and Steroid Dependent Nephrotic Syndrome Treated with Oral Cyclophosphamide: A Retrospective Cohort Study.Indian Pediatr2026https://conductscience.org/library/papers/42867774PubMed
39513526Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.Cochrane Database Syst Rev2024https://conductscience.org/library/papers/39513526PubMed
33786660Oral cyclophosphamide therapy in 100 children with steroid-sensitive nephrotic syndrome: experience from a developing country.Pediatr Nephrol2021https://conductscience.org/library/papers/33786660PubMed
33506028CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease.Biomed Res Int2021https://conductscience.org/library/papers/33506028PubMed
32297308Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.Cochrane Database Syst Rev2020https://conductscience.org/library/papers/32297308PubMed
30121800Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome.Clin Exp Nephrol2019https://conductscience.org/library/papers/30121800PubMed
27108294Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.Clin Exp Nephrol2017https://conductscience.org/library/papers/27108294PubMed
27054016Immunosuppressive therapy in children with steroid-resistant, frequently-relapsing, and steroid-dependent idiopathic nephrotic syndrome: a single center experience.Electron Physician2016https://conductscience.org/library/papers/27054016PubMed
25785660Corticosteroid therapy for nephrotic syndrome in children.Cochrane Database Syst Rev2015https://conductscience.org/library/papers/25785660PubMed
25653046Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy.Clin Exp Nephrol2015https://conductscience.org/library/papers/25653046PubMed
25190492Fertility preservation in patients receiving cyclophosphamide therapy for renal disease.Pediatr Nephrol2015https://conductscience.org/library/papers/25190492PubMed
22729760Is cyclophosphamide effective in patients with IgM-positive minimal change disease?Pediatr Nephrol2012https://conductscience.org/library/papers/22729760PubMed
22087198Complications of nephrotic syndrome.Korean J Pediatr2011https://conductscience.org/library/papers/22087198PubMed
21710249Cyclophosphamide followed by mizoribine as maintenance therapy against refractory steroid-dependent nephrotic syndrome.Pediatr Nephrol2011https://conductscience.org/library/papers/21710249PubMed
21399901Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome.Pediatr Nephrol2011https://conductscience.org/library/papers/21399901PubMed
21394465Cyclophosphamide in steroid-dependent nephrotic syndrome.Pediatr Nephrol2011https://conductscience.org/library/papers/21394465PubMed
19082635C1q nephropathy and minimal change nephrotic syndrome.Pediatr Nephrol2009https://conductscience.org/library/papers/19082635PubMed
16186679Treatment of steroid sensitive nephrotic syndrome.Indian J Pediatr2005https://conductscience.org/library/papers/16186679PubMed
16047223Long-term results of two unconventional agents in steroid-dependent nephrotic children.Pediatr Nephrol2005https://conductscience.org/library/papers/16047223PubMed
15968558Evidence-based management of steroid-sensitive nephrotic syndrome.Pediatr Nephrol2005https://conductscience.org/library/papers/15968558PubMed

See all 24 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2248508

GET https://conductscience.org/api/papers/v1/2248508/cited_by?page=2